相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Ruchi Kumari et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Dying to Survive-The p53 Paradox
Andrea Lees et al.
CANCERS (2021)
Forkhead Box M1 Transcription Facto or Drives Liver Inflammation Linking to Hepatocarcinagenesis in Mice
Tomohide Kurahashi et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer
Vaibhav Chand et al.
MOLECULAR CANCER RESEARCH (2019)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
Activation of AKT/AP1/FoxM1 signaling confers sorafenib resistance to liver cancer cells
Dongjing Yan et al.
ONCOLOGY REPORTS (2019)
Nucleoporin Nup155 is part of the p53 network in liver cancer
Kerstin Holzer et al.
NATURE COMMUNICATIONS (2019)
Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer
Elisabeth Drucker et al.
CELL COMMUNICATION AND SIGNALING (2019)
DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism
Ling Chen et al.
EPIGENETICS & CHROMATIN (2019)
Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma
M. Hope Robinson et al.
SCIENTIFIC REPORTS (2019)
HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma
Cheuk-Ting Law et al.
HEPATOLOGY (2019)
Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma
Chuan Tian et al.
GENE THERAPY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2018)
Mechanisms of transcriptional regulation by p53
Kelly D. Sullivan et al.
CELL DEATH AND DIFFERENTIATION (2018)
Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM
Kurt Engeland
CELL DEATH AND DIFFERENTIATION (2018)
Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer
Sofia M. E. Weiler et al.
GASTROENTEROLOGY (2017)
Census and evaluation of p53 target genes
M. Fischer
ONCOGENE (2017)
RASAL1 is a potent regulator of hepatic stellate cell activity and liver fibrosis
Akemi Takata et al.
ONCOTARGET (2017)
EGLN1/c-Myc Induced Lymphoid-Specific Helicase Inhibits Ferroptosis through Lipid Metabolic Gene Expression Changes
Yiqun Jiang et al.
THERANOSTICS (2017)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer
Kerstin Holzer et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Jordi Bruix et al.
GASTROENTEROLOGY (2016)
A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer
Daniel Dauch et al.
NATURE MEDICINE (2016)
Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells
Neil T. Pfister et al.
GENES & DEVELOPMENT (2015)
Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex
Martin Fischer et al.
ONCOTARGET (2015)
Prosurvival Function of the Cellular Apoptosis Susceptibility/Importin-α1 Transport Cycle Is Repressed by p53 in Liver Cancer
Juliane Winkler et al.
HEPATOLOGY (2014)
Metabolic Regulation by p53 Family Members
Celia R. Berkers et al.
CELL METABOLISM (2013)
The Forkhead Transcription Factor FOXM1 Controls Cell Cycle-Dependent Gene Expression through an Atypical Chromatin Binding Mechanism
Xi Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
FOXM1: From cancer initiation to progression and treatment
Chuay-Yeng Koo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2012)
p53 can repress transcription of cell cycle genes through a p21WAF1/CIP1-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements
Marianne Quaas et al.
CELL CYCLE (2012)
The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation
Bjoern von Eyss et al.
EMBO JOURNAL (2012)
E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression
Luis A. Carvajal et al.
GENES & DEVELOPMENT (2012)
The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence
Ozlem Aksoy et al.
GENES & DEVELOPMENT (2012)
Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect
Renee F. Johnson et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
Deregulation of FoxM1b leads to tumour metastasis
Hyun Jung Park et al.
EMBO MOLECULAR MEDICINE (2011)
One Function-Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor
Levin Boehlig et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer
Diego F. Calvisi et al.
JOURNAL OF HEPATOLOGY (2011)
NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration
Claudio Mauro et al.
NATURE CELL BIOLOGY (2011)
A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
Stephanie Roessler et al.
CANCER RESEARCH (2010)
Transcriptional Regulation by p53
Rachel Beckerman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC
D. F. Calvisi et al.
GUT (2009)
Pro-proliferative FoxM1 is a target of p53-mediated repression
A. M. Barsotti et al.
ONCOGENE (2009)
Redefining the p53 response element
Bei Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
Hiroshi Tazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Tsung-Cheng Chang et al.
MOLECULAR CELL (2007)
A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment
Galina A. Gusarova et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Identification of multiple distinct Snf2 subfamilies with conserved structural motifs
Andrew Flaus et al.
NUCLEIC ACIDS RESEARCH (2006)
Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor
VV Kalinichenko et al.
GENES & DEVELOPMENT (2004)
Transcriptional repression by p53 through direct binding a novel DNA element
RA Johnson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
